UK regulator reviewing AstraZeneca's US$39bil Alexion buyout


The UK's Competition and Markets Authority (CMA) said on Tuesday it was inviting comments from any interested party on the deal to help its assessment, a routine carried out for major deals, and set a deadline of June 3 for any submissions

LONDON: Britain's competition regulator is reviewing AstraZeneca's planned US$39 billion takeover of U.S.-based Alexion on whether it could reduce competition in Britain or other markets.

The UK's Competition and Markets Authority (CMA) said on Tuesday it was inviting comments from any interested party on the deal to help its assessment, a routine carried out for major deals, and set a deadline of June 3 for any submissions.

Get 30% off with our ads free Premium Plan

Monthly Plan

RM9.73/month

Annual Plan

RM8.63/month

Billed as RM103.60/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

AstraZeneca , buyout , Alexion , UK , regulator , reviewing ,

   

Next In Business News

CPO futures likely to trade lower on profit-taking next week
Oil notches weekly gains ahead of Opec+ decision
Hektar-REIT focuses on strengthening portfolio
Timber furniture sales cool as demand softens in US, Europe
Fading population dividend
CTOS eyes new overseas markets to drive growth
Big wins for billionaire Ambani in Disney tie-up
HAS inks deal for five new Airbus helicopters
Positive outlook for luxury condo market
China quants making big cap bets weather turmoil

Others Also Read